breakthrough
new MND drug could
delay progression
A drug with the potential to delay
would undertake formal pre-clinical believe the same inflammatory
the progression of motor neuron safety trials with the drug. pathway is likely to be active in all
trials within three years. “As long as the results from the
disease (MND) could be in human
forms of MND,” Dr Woodruff said.
safety studies are positive, the drug “Our next project will focus on
University of Queensland could be ready to be trialled in sporadic MND, which accounts for
researchers have shown the patients in 2019,” Dr Woodruff said. 90 per cent of patients.”
is effective in animals with the He also has plans to test the drug There is no known cure for
disease, delaying the progression in a range of motor neuron disease MND, a terminal disease with an
of symptoms and extending models in his laboratory. average life expectancy of two
anti-inflammatory drug PMX205
survival.
and a half years. People with MND
“To date we have only tested the progressively lose the use of their
Associate Professor Trent drug in one model based on the limbs and ability to speak, swallow
Woodruff said a private company inherited form of MND, but we and breathe.
Do you have a problem
with your telephone or
internet company?
The Telecommunications
Industry Ombudsman
can help.
Remember, before you get in touch with us,
you need to try to fix your problem with your
landline, mobile or internet company.
Call us: 1800 062 058*
Go online: www.tio.com.au
Interpreting service:
131 450
For more information,
visit: www.relayservice.gov.au
*Calls to our 1800 number from landlines are free. Calls from mobile phones
may attract a fee, which will vary depending on your service provider. If you
are calling from a mobile phone, let us know and we can call you back.
54
breakthrough
linkonline.com.au